Iloperidone
VP-VYV-683-1004
Phase 3 small_molecule completed
Quick answer
Iloperidone for Bipolar I Disorder is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Bipolar I Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed